261 related articles for article (PubMed ID: 23388170)
1. Metabolic syndrome and cognitive decline in early Alzheimer's disease and healthy older adults.
Watts AS; Loskutova N; Burns JM; Johnson DK
J Alzheimers Dis; 2013; 35(2):253-65. PubMed ID: 23388170
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome and cognitive function in healthy middle-aged and older adults without diabetes.
Gatto NM; Henderson VW; St John JA; McCleary C; Hodis HN; Mack WJ
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2008 Sep; 15(5):627-41. PubMed ID: 18608045
[TBL] [Abstract][Full Text] [Related]
3. Low cerebral blood flow is associated with lower memory function in metabolic syndrome.
Birdsill AC; Carlsson CM; Willette AA; Okonkwo OC; Johnson SC; Xu G; Oh JM; Gallagher CL; Koscik RL; Jonaitis EM; Hermann BP; LaRue A; Rowley HA; Asthana S; Sager MA; Bendlin BB
Obesity (Silver Spring); 2013 Jul; 21(7):1313-20. PubMed ID: 23687103
[TBL] [Abstract][Full Text] [Related]
4. Association between Cognitive Function and Clustered Cardiovascular Risk of Metabolic Syndrome in Older Adults at Risk of Cognitive Decline.
Lai MMY; Ames DJ; Cox KL; Ellis KA; Sharman MJR; Hepworth G; Desmond P; Cyarto EV; Szoeke C; Martins R; Masters CL; Lautenschlager NT
J Nutr Health Aging; 2020; 24(3):300-304. PubMed ID: 32115611
[TBL] [Abstract][Full Text] [Related]
5. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Syndrome and Cognitive Trajectories in the Framingham Offspring Study.
Bangen KJ; Armstrong NM; Au R; Gross AL
J Alzheimers Dis; 2019; 71(3):931-943. PubMed ID: 31450495
[TBL] [Abstract][Full Text] [Related]
7. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile.
Smits LL; Pijnenburg YA; Koedam EL; van der Vlies AE; Reuling IE; Koene T; Teunissen CE; Scheltens P; van der Flier WM
J Alzheimers Dis; 2012; 30(1):101-8. PubMed ID: 22366769
[TBL] [Abstract][Full Text] [Related]
8. Contribution of Components of Metabolic Syndrome to Cognitive Performance in Middle-Aged Adults.
Bahchevanov KM; Dzhambov AM; Chompalov KA; Massaldjieva RI; Atanassova PA; Mitkov MD
Arch Clin Neuropsychol; 2021 May; 36(4):498-506. PubMed ID: 33067992
[TBL] [Abstract][Full Text] [Related]
9. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.
Gomar JJ; Bobes-Bascaran MT; Conejero-Goldberg C; Davies P; Goldberg TE;
Arch Gen Psychiatry; 2011 Sep; 68(9):961-9. PubMed ID: 21893661
[TBL] [Abstract][Full Text] [Related]
10. Age related characteristics of cognitive changes in patients with metabolic syndrome.
Bezrukov VV; Bachinskaya NY; Kopchak OO; Kholin VO; Pulyk OR
Wiad Lek; 2018; 71(8):1515-1523. PubMed ID: 30684334
[TBL] [Abstract][Full Text] [Related]
11. Does medial temporal lobe thickness mediate the association between risk factor burden and memory performance in middle-aged or older adults with metabolic syndrome?
McIntosh EC; Jacobson A; Kemmotsu N; Pongpipat E; Green E; Haase L; Murphy C
Neurosci Lett; 2017 Jan; 636():225-232. PubMed ID: 27717834
[TBL] [Abstract][Full Text] [Related]
12. Elevated cerebral glutamate and myo-inositol levels in cognitively normal middle-aged adults with metabolic syndrome.
Haley AP; Gonzales MM; Tarumi T; Miles SC; Goudarzi K; Tanaka H
Metab Brain Dis; 2010 Dec; 25(4):397-405. PubMed ID: 21063759
[TBL] [Abstract][Full Text] [Related]
13. Is there an association between metabolic syndrome and cognitive function in very old adults? The Newcastle 85+ Study.
Harrison SL; Stephan BC; Siervo M; Granic A; Davies K; Wesnes KA; Kirkwood TB; Robinson L; Jagger C
J Am Geriatr Soc; 2015 Apr; 63(4):667-75. PubMed ID: 25850570
[TBL] [Abstract][Full Text] [Related]
14. Predicting disease progression in Alzheimer's disease: the role of neuropsychiatric syndromes on functional and cognitive decline.
Palmer K; Lupo F; Perri R; Salamone G; Fadda L; Caltagirone C; Musicco M; Cravello L
J Alzheimers Dis; 2011; 24(1):35-45. PubMed ID: 21157019
[TBL] [Abstract][Full Text] [Related]
15. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
[TBL] [Abstract][Full Text] [Related]
16. Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease.
Liu-Seifert H; Siemers E; Price K; Han B; Selzler KJ; Henley D; Sundell K; Aisen P; Cummings J; Raskin J; Mohs R;
J Alzheimers Dis; 2015; 47(1):205-14. PubMed ID: 26402769
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Syndrome and Cognitive Function in Midlife.
Foret JT; Oleson S; Hickson B; Valek S; Tanaka H; Haley AP
Arch Clin Neuropsychol; 2021 Aug; 36(6):897-907. PubMed ID: 33283221
[TBL] [Abstract][Full Text] [Related]
18. Cognitive decline in normal ageing and early Alzheimer's disease: a continuous or discontinuous transition?
Spaan PE; Dolan CV
Behav Neurol; 2010; 23(4):203-6. PubMed ID: 21422555
[No Abstract] [Full Text] [Related]
19. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.
Frisardi V; Solfrizzi V; Seripa D; Capurso C; Santamato A; Sancarlo D; Vendemiale G; Pilotto A; Panza F
Ageing Res Rev; 2010 Oct; 9(4):399-417. PubMed ID: 20444434
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome.
Kim B; Feldman EL
Exp Mol Med; 2015 Mar; 47(3):e149. PubMed ID: 25766618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
